Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06529991 · ClinicalTrials.gov registry record · NA
Self-Myofascial Release of the Upper Cervical Muscles
A NA study of Suboccipital Muscles and Superficial Back Line, sponsored by Edward Via Virginia College of Osteopathic Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06529991: Recruiting NA study of Suboccipital Muscles and Superficial Back Line, sponsored by Edward Via Virginia College of Osteopathic Medicine.
NCT06529991 is a NA study of Suboccipital Muscles and Superficial Back Line that is actively recruiting participants, run by Edward Via Virginia College of Osteopathic Medicine. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06529991, a NA study of Suboccipital Muscles and Superficial Back Line, is actively recruiting participants, sponsored by Edward Via Virginia College of Osteopathic Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to examine the influence of the suboccipital muscles on the superficial back line. The investigators will measure the following as part of this objective: * Changes in biomechanical and viscoelastic properties of points within the superficial back fascial train measured by a handheld myotonometer. * Pain pressure threshold measured by algometry. * Ankle range of motion. * Foot plantar pressure changes. All participants will have a 5-minute self-myofascial release intervention.
Primary Outcome
Using myotonometry to assess muscle stiffness (N/m) in the plantar fascia, gastrocnemius, biceps femoris, semitendinosus, thoracolumbar fascia, and semispinalis.
Conditions Studied
Interventions
- DEVICE Occipivot suboccipital pillow self-myofascial release
Study Locations (1)
Alabama
- Edward Via College of Osteopathic Medicine-Auburn - Auburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-06-26 |
| Est. Completion | 2026-04-26 |
| Phase | NA |
What NCT06529991 shows while recruiting
NCT06529991 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Suboccipital Muscles appearing as the primary indexed condition, and to 1 intervention - of which Occipivot suboccipital pillow self-myofascial release is the first listed.
NCT06529991 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06529991 about?
NCT06529991 is a clinical study titled "Self-Myofascial Release of the Upper Cervical Muscles". The primary objective is to examine the influence of the suboccipital muscles on the superficial back line. The investigators will measure the following as part of this objective: * Changes in biomechanical and viscoelastic properties of points within the superficial back fascial train measured by ...
What is the current status of trial NCT06529991?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-06-26. Estimated completion is 2026-04-26.
What conditions does trial NCT06529991 study?
This clinical trial studies the following conditions: Suboccipital Muscles, Superficial Back Line, Myofascial Release.
What interventions are being tested in trial NCT06529991?
The interventions under investigation include: Occipivot suboccipital pillow self-myofascial release (DEVICE).
Who is sponsoring clinical trial NCT06529991?
This trial is sponsored by Edward Via Virginia College of Osteopathic Medicine, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06529991 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06529991's enrollment target sits among peer trials
30 1594th of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI